Skip to main content

and
  1. No Access

    Article

    Evaluation of breast cosmetic changes with a computer-software; the breast cancer conservative treatment cosmetic results (BCCT. core) in hypofractionated whole breast irradiation after breast-conserving surgery-supplementary analysis of multicenter single-arm confirmatory trial: JCOG0906

    A good cosmetic outcome has been defined as an important endpoint in breast-conserving therapy (BCT). Various evaluation methods have been studied, but the optimal method has yet to be identified. The present ...

    Miwako Nozaki, Yoshikazu Kagami, Mitsuhiro Takahashi, Ryunosuke Machida in Breast Cancer (2022)

  2. Article

    Open Access

    A pictorial essay on radiological changes after stereotactic body radiation therapy for lung tumors

    Stereotactic body radiation therapy (SBRT) is a frequently used modality for the treatment of early stage non-small cell lung cancer and oligometastatic disease of the lung. The radiological changes observed i...

    Yasuo Matsumoto in Japanese Journal of Radiology (2022)

  3. No Access

    Article

    Present clinical practices of stereotactic irradiation for metastatic brain tumors in Japan: results of questionnaire survey of the Japanese Radiation Oncology Study Group (JROSG) working subgroup for neurological tumors

    To determine the current practice of stereotactic irradiation (STI) for brain metastases in Japan by a questionnaire survey.

    Ken Harada, Hiroshi Igaki, Eisuke Abe in International Journal of Clinical Oncology (2018)

  4. No Access

    Article

    Timing and characteristics of radiation pneumonitis after stereotactic body radiotherapy for peripherally located stage I lung cancer

    This study was conducted to determine the timing and characteristics of radiation pneumonitis (RP) associated with stereotactic body radiotherapy (SBRT) for stage I lung cancer.

    Ayae Kanemoto, Yasuo Matsumoto in International Journal of Clinical Oncology (2015)

  5. Article

    Open Access

    Local effect of stereotactic body radiotherapy for primary and metastatic liver tumors in 130 Japanese patients

    Stereotactic body radiotherapy (SBRT) is a relatively new treatment for liver tumor. The outcomes of SBRT for liver tumor unfit for ablation and surgical resection were evaluated.

    Hideomi Yamashita, Hiroshi Onishi, Yasuo Matsumoto, Naoya Murakami in Radiation Oncology (2014)

  6. Article

    Open Access

    Multi-institutional comparison of treatment planning using stereotactic ablative body radiotherapy for hepatocellular carcinoma – benchmark for a prospective multi-institutional study

    Several single institution phase I and phase II trials of stereotactic ablative body radiotherapy (SABR) for liver tumors have reported promising results and high local control rates of over 90%. However, ther...

    Takahisa Eriguchi, Atsuya Takeda, Yohei Oku, Satoshi Ishikura in Radiation Oncology (2013)

  7. No Access

    Article

    Long-term results of chemoradiotherapy for locally advanced esophageal cancer, using daily low-dose 5-fluorouracil and cis-diammine-dichloro-platinum (CDDP)

    We evaluated the efficacy and toxicity of radiation combined with daily, low-dose protracted chemotherapy for locally advanced esophageal cancer.

    Ryuta Sasamoto, Kunio Sakai, Hideki Inakoshi in International Journal of Clinical Oncology (2007)

  8. No Access

    Article

    Risk factors for enlargement of cardiac silhouette on chest radiography after radiotherapy for esophageal cancer

    To evaluate the incidence and risk factors of enlargement of cardiac silhouette on chest radiographs after radiotherapy for esophageal cancer.

    Ryuta Sasamoto, Emiko Tsuchida, Tadashi Sugita, Yasuo Matsumoto in Radiation Medicine (2006)

  9. No Access

    Article

    Concurrent chemoradiotherapy using low-dose continuous infusion of 5-fluorouracil for postoperative regional lymph node recurrence of esophageal squamous cell carcinoma

    Radiotherapy plays an important role in salvaging patients who suffer locoregional recurrence; however, it displays poor prognosis. Because concurrent chemoradiotherapy offers superior treatment results compar...

    Emiko Tsuchida, Kunio Sakai, Yasuo Matsumoto, Tadashi Sugita, Ryuta Sasamoto in Esophagus (2005)

  10. No Access

    Article

    Preparation of a Layered Titanoniobic Acid—Alumina Nanocomposite and Its Potential Applicability to Removal of Organic Contaminants in Water

    A nanocomposite of layered titanoniobic acid, HTiNbO5 with aluminum oxides was prepared by a pillaring technique. HTiNbO5 was intercalated with aluminum polyoxocations through displacement of the pre-intercalated...

    Teruyuki Nakato, Yasuo Matsumoto in Journal of Porous Materials (2004)

  11. No Access

    Article

    Allelic loss map** and physical delineation of a region harboring a putative thymic lymphoma suppressor gene on mouse chromosome 12

    Our previous allelic loss analysis of γ-ray induced thymic lymphomas in F1 hybrid and backcross mice between BALB/c and MSM strains mapped the Tlsr4 region exhibiting a high frequency of allelic loss (62%) to a 2...

    Toshimitsu Shinbo, Atsushi Matsuki, Yasuo Matsumoto, Shin-ichi Kosugi in Oncogene (1999)

  12. No Access

    Article

    Allelic loss analysis of γ-ray-induced mouse thymic lymphomas: two candidate tumor suppressor gene loci on chromosomes 12 and 16

    A total of 429 γ-ray-induced thymic lymphomas were obtained from F1 and backcross mice between BALB/c and MSM strains, about a half of which carried a p53-deficient allele. A genome-wide allelic loss analysis has...

    Yasuo Matsumoto, Shin-ichi Kosugi, Toshimitsu Shinbo, Daizen Chou in Oncogene (1998)